Annual Meeting 2018   |   ASGCT News

ASGCT 2018 Election Results

ASGCT Staff - April 23, 2018

Four elected members join the Board of Directors at the 21st Annual Meeting.

After a monthlong election, members of the American Society of Gene & Cell Therapy have elected four new members to the Society's Board of Directors, including a new incoming vice president.

Each elected member will serve a three-year term, including the incoming vice president who will enter the leadership succession line. Stephen Russell, MD, PhD will serve a yearlong term as vice president before serving as ASGCT's president-elect and, finally, president through the 2021 annual meeting.

All four of the following newly-elected members will begin their terms on the Board of Directors during the 21st Annual Meeting next month at the Hilton Chicago:

Vice President

Stephen Russell, MD, PhD
Mayo Clinic

Translational and Clinical Development Representative

Richard Morgan, PhD
bluebird bio

At-Large Director

Jennifer Adair, PhD
Fred Hutchinson Cancer Research Center

At-Large Director

Stephen Hart, PhD
UCL Great Ormond Street Institute of Child Health


Congratulations to the incoming members of the ASGCT Board of Directors!

Related Articles

ASGCT News

ASGCT Statement of Support for the Asian, Asian-American and Pacific Islander Communities

ASGCT Board of Directors - April 27, 2021
ASGCT News

Gene, Cell, & RNA Therapy Landscape: Q1 2021

David M. Barrett, J.D., M.S. - April 15, 2021
ASGCT News

New Diversity and Inclusion Awards Aim to Promote Equity in Gene and Cell Therapy Research

David Barrett, J.D., M.S. - February 26, 2021
ASGCT News

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. - December 18, 2020